Compare AbCellera Biologics Inc (ABCL) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Enveric Biosciences Inc — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: AbCellera Biologics Inc is far larger — about 482.3× Enveric Biosciences Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | ENVB | |
|---|---|---|
Market Cap | $2.99B | $6.20M |
Sector | Health | Health |
52-Week High | $9.76 | $17.40 |
52-Week Low | $2.78 | $1.27 |
Enterprise Value | $2.58B | $1.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
